fda glp-1 compounding enforcement september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA is short-sighted on compounding

Table 1 organizes recent studies investigating the use of GLP analogs and DPP-IV inhibitors in IBD by study design, treatment arm, key results, and evidence classification with risk-of-bias assessment

I lost 50 pounds in just under a year on Ozempic

A microdosing approach may maintain therapeutic benefit while reducing side effect severity

Williams husband, Reddit co-founder Alexis Ohanian, is a Ro investor and is on its board

GLP-1 agonists taken once a week typically cause fewer side effects, but no one wants to start with a week of nausea or vomiting

Now her friends make fun of how much hot sauce she pours on her meals